Fake Drugs and Counterfeit Medicine Concerns in India
Fake drugs in India: Karnataka's unconfirmed cancer drug seizure raises public health concerns. Learn about counterfeit medicine laws and challenges.
- GS 2: Social Justice
- GS-II Social Justice
- GS-III Science & Technology

PadhAI Editorial Team
The Hindu
6
mins Reading time
Add a comment

Join our WhatsApp Community
Why Is Fake Drugs in the News?
A licensed distributor in Karnataka was allegedly found with counterfeit cancer drugs. However, the State Government has not confirmed this, creating uncertainty for patients and families.
Key Highlights of the Fake Drugs Issue
The circulated list of seized drugs reportedly included antibiotics, not cancer drugs, causing public confusion.
Karnataka's Health Department has not clarified whether cancer drugs were involved or named affected hospitals.
The 2017 National Drug Survey found counterfeit drugs in only 0.0245% of sampled medicines in India.
Counterfeiters often target cosmetics and fast-moving consumer goods due to lower legal risks and porous supply chains.
Pharmacies can invoke Section 19(3) of the Drugs and Cosmetics Act, 1940, if they maintain purchase records.
Anti-counterfeiting technology providers lobby for costly measures, raising concerns about compliance costs for patients.
Counterfeit Medicine and Drug Laws: Basics to Know
Counterfeit drugs: Medicines that are mislabelled, substandard, or contain incorrect ingredients.
Drugs and Cosmetics Act, 1940: Governs the manufacture, sale, and distribution of drugs in India.
Good Distribution Practices (GDP): WHO guidelines for medicine storage and distribution, pending in India for over a decade.
Fake Drugs Issue Explained
Uncertainty Around Karnataka's Seizure
The State Government has not confirmed whether cancer drugs were seized, despite public fear.
A press release or conference is needed to clarify the situation and protect public health.
Low Prevalence of Counterfeit Drugs
The 2017 National Drug Survey found counterfeit drugs in only 0.0245% of samples, contradicting exaggerated claims.
Routine drug inspections by authorities ensure low prevalence in India.
Challenges in Enforcement
Counterfeiters prefer non-drug products due to weaker legal oversight and easier supply chain infiltration.
Pharmacies and distributors with proper purchase records are protected under Section 19(3) of the Drugs and Cosmetics Act.
Policy and Cost Concerns
Anti-counterfeiting technologies are expensive and may increase drug prices for patients.
The Ministry of Health must balance effective measures with affordability.
Significance of Counterfeit Drug Control for India
Ensuring public health by preventing the distribution of substandard or harmful medicines.
Maintaining trust in India's pharmaceutical industry, a major global supplier.
UPSC could test this under governance, public health, or science and technology topics.
Strengthening legal and logistical frameworks for drug distribution can reduce vulnerabilities.
Challenges in India's Drug Regulation
Lack of a licensing framework for entities transporting medicines between manufacturers and retailers.
Pending adoption of WHO's Good Distribution Practices for over a decade.
Disproportionate media focus on counterfeit drugs despite their low prevalence.
High compliance costs for anti-counterfeiting technologies may burden patients.
Way Forward for Counterfeit Drug Control
Karnataka's Health Department should clarify the seizure details to address public concerns.
The Ministry of Health must implement WHO's Good Distribution Practices to improve supply chain security.
Parliament should introduce a licensing framework for medicine transport entities.
Anti-counterfeiting measures should be proportionate to the problem and minimise cost impacts on patients.
PYQs (Prelims)
Question 1 of 3
Your Score: 0/3
Prelims Practice Quiz
Consider the following statements about counterfeit drugs in India:
How many of the above statements are correct?
- 1The 2017 National Drug Survey found counterfeit drugs in 0.0245% of sampled medicines.
- 2Pharmacies without purchase records can invoke Section 19(3) of the Drugs and Cosmetics Act, 1940.
- 3Counterfeiters often target cosmetics and fast-moving consumer goods due to lower legal risks.
Frequently Asked Questions
Have questions about this article? Find answers to everything you need to know.
Q1
What are counterfeit drugs?
Counterfeit drugs are medicines that are mislabelled, substandard, or contain incorrect ingredients, posing risks to public health.
What is Section 19(3) of the Drugs and Cosmetics Act?
Section 19(3) provides statutory protection to pharmacies and distributors if they maintain proper purchase records for drugs.
Why is Karnataka's fake drugs case controversial?
The Karnataka case is controversial because the State Government has not confirmed whether counterfeit cancer drugs were seized, causing public confusion.
Add as a preferred Source on Google
No comments yet. Be the first to join the discussion!





















